Histone Deacetylase-2 Expression in Colorectal Cancer: An Immunohistochemical Study and Its Clinicopathological Significance
Cancers · 02.05.2026 · 18 (9) · 1466
DOI: 10.3390/cancers18091466 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancers, online erschienen am 02.05.2026. Verfasst von Nikolaos Garmpis und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Colorectal Surgery, Guys and St Thomas' Hospital, London SE1 7EH, UK. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/Objectives: Colorectal cancer (CRC) remains a leading cause of cancer-related mortality and is characterized by substantial molecular heterogeneity, including epigenetic dysregulation. Histone acetylation, regulated by histone acetyltransferases and histone deacetylases (HDAC), has been implicated in CRC development and progression. The aim of the present study was to evaluate HDAC-2 expression in CRC and investigate its association with clinicopathological parameters and patient outcomes.
Methods
In this retrospective study, tumor tissue samples from 77 patients with CRC and documented recurrence were examined. HDAC-2 expression was assessed by immunohistochemistry and classified as low or high using a semi-quantitative scoring system. Associations with clinicopathological parameters and survival outcomes (disease-free survival, DFS; overall survival, OS) were analyzed.
Results
High HDAC-2 expression was associated with younger patient age and earlier disease recurrence, while its association with overall survival was borderline.
Conclusions
HDAC-2 expression may have clinicopathological relevance in CRC, particularly in relation to recurrence-related outcomes, although larger studies are needed to confirm its prognostic significance.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Colorectal Surgery, Guys and St Thomas' Hospital, London SE1 7EH, UK.
- Second Department of Propedeutic Surgery, Laiko General Hospital, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece.
- N.S. Christeas Laboratory of Experimental Surgery and Surgical Research, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece.
- First Department of Pathology, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece.
- First Surgical Department, University Hospital of Alexandroupolis, Democritus University of Thrace, Dragana, 68100 Alexandroupolis, Greece.
- 8th Department of Internal Medicine, Ygeia General Hospital, 15123 Athens, Greece.
ORCID-Profile: Nikolaos Garmpis, Eleni I Effraimidou, Anna Garmpi, Christos Damaskos
Zitieren
APA
Garmpis, N., Nonni, A., Dimitroulis, D., Effraimidou, E. I., Garmpi, A., Papandroudis, M. P., Kontzoglou, K., & Damaskos, C. (2026). Histone Deacetylase-2 Expression in Colorectal Cancer: An Immunohistochemical Study and Its Clinicopathological Significance. Cancers, 18(9), 1466. https://doi.org/10.3390/cancers18091466
Vancouver
Garmpis N, Nonni A, Dimitroulis D, Effraimidou EI, Garmpi A, Papandroudis MP, et al. Histone Deacetylase-2 Expression in Colorectal Cancer: An Immunohistochemical Study and Its Clinicopathological Significance. Cancers. 2026;18(9):1466. doi:10.3390/cancers18091466
BibTeX
@article{Garmpis2026,
author = {Garmpis, Nikolaos and Nonni, Afroditi and Dimitroulis, Dimitrios and Effraimidou, Eleni I and Garmpi, Anna and Papandroudis, Miltiadis-Panagiotis and Kontzoglou, Konstantinos and Damaskos, Christos},
title = {Histone Deacetylase-2 Expression in Colorectal Cancer: An Immunohistochemical Study and Its Clinicopathological Significance},
journal = {Cancers},
year = {2026},
volume = {18},
number = {9},
pages = {1466},
doi = {10.3390/cancers18091466}
}
EUVIMED